Debiopharm Group

Debiopharm is an independent biopharmaceutical company based in Switzerland, engaged in the licensing of promising biologics and small molecule drug candidates, committed to improving the prognosis and quality of life for patients with cancer and bacterial infections. Our core businesses include drug development, drug manufacturing, and digital health investment. The products they develop are intended for global registration and maximum commercial potential, with sales and marketing licenses granted to pharmaceutical partners.